G. Skowron

发表

Pharmacokinetic Evaluation and Short-Term Activity of Stavudine, Nevirapine, and Nelfinavir Therapy in HIV-1–Infected Adults

T. Macgregor, M. Jacobs, D. Hall, 2004, Journal of acquired immune deficiency syndromes.

Identification of a potent regulatory T cell epitope in factor V that modulates CD4+ and CD8+ memory T cell responses.

A. D. De Groot, A. Rosenberg, W. Martin, 2021, Clinical immunology.

Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C

Z. Younossi, G. Cholankeril, Aijaz Ahmed, 2016, Digestive Diseases and Sciences.

Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction

J. White, A. D. De Groot, D. Serreze, 2019, Scientific Reports.

A Phase I/II Evaluation of Oral L‐2‐Oxothiazolidine‐4‐Carboxylic Acid in Asymptomatic Patients Infected with Human Immunodeficiency Virus

M. Lederman, D. Noe, P. Barditch-Crovo, 1998, Journal of clinical pharmacology.

Preventing transfusion‐transmitted babesiosis: preliminary experience of the first laboratory‐based blood donor screening program

P. Krause, J. Padbury, G. Skowron, 2012, Transfusion.

Persistent and relapsing babesiosis in immunocompromised patients.

M. Young, S. Telford, A. Spielman, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates

T. Wrin, C. Petropoulos, E. Paxinos, 2002, AIDS.

Alternating and intermittent regimens of zidovudine (3'-azido-3'-deoxythymidine) and dideoxycytidine (2',3'-dideoxycytidine) in the treatment of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

T. Merigan, G. Skowron, 1990, The American journal of medicine.

Treatment of HIV infection: the antiretroviral nucleoside analogues. Nucleoside analogues: monotherapy.

G. Skowron, 1992, Hospital practice.

Safety and tolerance of dideoxycytidine as a single agent: Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex

T. Merigan, G. Skowron, 1990 .

A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (procysteine) in asymptomatic HIV-infected subjects.

K. Mayer, J. B. Jackson, P. Borum, 1994, Journal of acquired immune deficiency syndromes.

dNN study: stavudine, nelfinavir and nevirapine. Preliminary safety, activity and pharmacokinetic interactions.

G. Skowron, 1998, Antiviral therapy.

Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study.

R. Schooley, M. Hirsch, T. Merigan, 1989, Annals of internal medicine.

Disseminated Fusarium Infections in Patients Receiving Posaconazole Prophylaxis: A Report of 2 Patients and Brief Review of the Literature

J. Fournier, D. Heiner, C. Breen, 2015 .

Serratia marcescens Bullous Cellulitis in a Splenectomized Patient

V. Falanga, J. Fournier, P. Carson, 2016, The international journal of lower extremity wounds.

Stavudine, Didanosine, and Zalcitabine

G. Skowron, M. Stevens, S. Chowdhry, 2006 .

2',3'‐Dideoxycytidine (ddC) toxic neuropathy

J C Arezzo, A R Berger, T. Merigan, 1993, Neurology.

Alternating and Intermittent Regimens of Zidovudine and Dideoxycytidine in Patients with AIDS or AIDS-Related Complex

T. Merigan, D. Richman, J. Arezzo, 1993, Annals of Internal Medicine.

Once-daily quadruple-drug therapy with adefovir dipivoxil, Lamivudine, Didanosine, and efavirenz in treatment-naive human immunodeficiency virus type 1-infected patients.

J. Tolson, D. Kuritzkes, K. Squires, 2002, The Journal of infectious diseases.

Baseline CD4(+) cell count, not viral load, correlates with virologic suppression induced by potent antiretroviral therapy.

G. Skowron, J. Street, E. M. Obee, 2001 .

A randomized study of the safety and antiretroviral activity of hydroxyurea combined with didanosine in persons infected with human immunodeficiency virus type 1. American Foundation for AIDS Research Community-Based Clinical Trials Network.

G. Accetta, M. Iwane, M. Giordano, 2000, The Journal of infectious diseases.

Replication Capacity in Relation to Immunologic and Virologic Outcomes in HIV-1-Infected Treatment-Naive Subjects

V. Johnson, G. Robbins, D. Asmuth, 2009, Journal of acquired immune deficiency syndromes.

Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.

R. Shafer, G. Robbins, D. Asmuth, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection.

M. Lederman, T. Merigan, M. Jacobson, 2003, The Journal of infectious diseases.

The safety and efficacy of granulocyte-macrophage colony-stimulating factor (Sargramostim) added to indinavir- or ritonavir-based antiretroviral therapy: a randomized double-blind, placebo-controlled trial.

J. Bilello, G. Drusano, K. Melbourne, 1999, The Journal of infectious diseases.

Biologic effects and safety of stavudine: overview of phase I and II clinical trials.

G. Skowron, 1995, The Journal of infectious diseases.

A novel real‐time CTL assay to measure designer T‐cell function against HIV Env+ cells

P. Marx, S. Braun, R. Junghans, 2014, Journal of medical primatology.

Anti-HIV designer T cells progressively eradicate a latently infected cell line by sequentially inducing HIV reactivation then killing the newly gp120-positive cells.

K. Sango, R. Junghans, N. Selliah, 2013, Virology.

gp1207‐directed antibody‐dependent cellular cytotoxicity as a major determinant of the rate of decline in CD4 percentage in HIV‐1 disease

G. Skowron, B. Cole, B. Yen‐Lieberman, 1997, AIDS.

Further progress on defining highly conserved immunogenic epitopes for a global HIV vaccine: HLA-A3-restricted GAIA vaccine epitopes

Anne S De Groot, Kenneth H Mayer, S. Buus, 2012, Human Vaccines & Immunotherapeutics.

Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity.

Z. Su, J. Reeves, T. Wilkin, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Zidovudine and dideoxycytidine differ in their effects on human immunodeficiency virus-induced pathologic activation of the immune system. AIDS Clinical Trial Research Group 047.

T. Merigan, W. Cumberland, J. Fahey, 1994, The Journal of infectious diseases.

Prolonged persistence of a novel replication-defective HIV-1 variant in plasma of a patient on suppressive therapy

G. Skowron, G. K. Sahu, R. Ramírez, 2016, Virology Journal.

Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach.

Judy Lieberman, Anne S De Groot, William Martin, 2003, Vaccine.

Although STDs affect people of all ages , sexually transmitted diseases in Primary care sexually transmitted diseases : introduction

Joseph A. Diaz, M. Neill, G. Skowron, 2022 .

Aspergillus meningitis in an immunocompetent adult successfully treated with itraconazole.

A. Sugar, D. Mikolich, L. Kinsella, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Influenza A H5N1 hemagglutinin cleavable signal sequence substitutions.

J. Weltman, G. Loriot, G. Skowron, 2007, Biochemical and biophysical research communications.

The HF-SCF energy of HIV-1 MNgp120 V3 hairpin loop conformers

J. Weltman, G. Loriot, G. Skowron, 2004, Journal of molecular modeling.

Lack of pharmacokinetic interaction between nelfinavir and nevirapine.

S. Beebe, G. Skowron, G. Leoung, 1998, AIDS.

Baseline CD4+ Cell Count, Not Viral Load, Correlates With Virologic Suppression Induced by Potent Antiretroviral Therapy

G. Skowron, J. Street, Gail Skowron, 2001, Journal of acquired immune deficiency syndromes.

Prolonged persistence of a novel replication-defective HIV-1 variant in plasma of a patient on suppressive therapy

G. Skowron, G. K. Sahu, R. Ramírez, 2016, Virology Journal.

2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial.

S. Steinberg, G. Curt, K. Mayer, 1993, The Journal of infectious diseases.

Safety and Effects of Interleukin‐2 Plus Zidovudine in Asymptomatic Individuals Infected with Human Immunodeficiency Virus

T. Merigan, D. Schwartz, G. Skowron, 1991, Journal of acquired immune deficiency syndromes.

Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity.

J. Reeves, T. Wilkin, R. Gulick, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.